Biotech · Private company
RHEACELL GmbH & Co. KG
Track this companyFree. Adds RHEACELL GmbH & Co. KG to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- allo-APZ2-CVUPhase 3 · Venous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- allo-APZ2-OTSPhase 3 · Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- allo-APZ2-EBPhase 2 · Recessive Dystrophic Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- LSC2Phase 2 · Limbal Stem Cell DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 26, 2024ClinicalTrials.gov NCT06489028 · fetched Nov 12, 2026
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 18, 2023ClinicalTrials.gov NCT05838092 · fetched Nov 12, 2026
- Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCDPHASE1_PHASE2 · UNKNOWN · started Jul 4, 2019ClinicalTrials.gov NCT03549299 · fetched Nov 12, 2026
- Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis BullosaPHASE1_PHASE2 · COMPLETED · started Feb 16, 2019ClinicalTrials.gov NCT03529877 · fetched Nov 12, 2026